MELTECH Trademark

Trademark Overview


On Thursday, November 3, 2016, a trademark application was filed for MELTECH with the United States Patent and Trademark Office. The USPTO has given the MELTECH trademark a serial number of 79203791. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, July 31, 2024. This trademark is owned by Dexcel Pharma Technologies Ltd.. The MELTECH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the form of orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, [ cardiovascular, ] central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, [ dermatological, ] infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, [ ophthalmologic, ] psychiatric, respiratory, [ urogenital, urological, erectile dysfunction, sexual dysfunction, ] gynecology, obstetric, [ pediatric, hematologic, ] oncological, fungal and viral diseases and disorders
meltech

General Information


Serial Number79203791
Word MarkMELTECH
Filing DateThursday, November 3, 2016
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, July 31, 2024
Registration Number5332139
Registration DateTuesday, November 14, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 29, 2017

Trademark Statements


Description of MarkThe mark consists of the word "MELTECH" appearing in stylized blue font with a stylized blue "M" appearing to the left of the wording and extending under the letters "MEL".
Goods and ServicesPharmaceutical preparations in the form of orally disintegrating tablets and orally disintegrating medicaments for the treatment of genetic, [ cardiovascular, ] central nervous system, endocrine, gastrointestinal, hepatic, biliary, immunological, allergic, pulmonary, [ dermatological, ] infectious, inflammatory, menopausal, nutritional, metabolic, diabetes, autoimmune, musculoskeletal, connective tissue, neurological, [ ophthalmologic, ] psychiatric, respiratory, [ urogenital, urological, erectile dysfunction, sexual dysfunction, ] gynecology, obstetric, [ pediatric, hematologic, ] oncological, fungal and viral diseases and disorders
Pseudo MarkMEL TECH
Indication of Colors claimedThe color(s) blue is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDexcel Pharma Technologies Ltd.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressJerusalem 9123901
IL

Party NameDexcel Pharma Technologies Ltd.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressIL

Party NameDexcel Pharma Technologies Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressIL

Trademark Events


Event DateEvent Description
Thursday, March 23, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 27, 2017ASSIGNED TO EXAMINER
Friday, April 7, 2017REFUSAL PROCESSED BY MPU
Friday, March 31, 2017APPLICATION FILING RECEIPT MAILED
Thursday, April 6, 2017NON-FINAL ACTION WRITTEN
Friday, April 7, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 7, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, April 29, 2017REFUSAL PROCESSED BY IB
Wednesday, June 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 9, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, February 14, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, February 22, 2018FINAL DISPOSITION PROCESSED
Thursday, February 22, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 13, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 14, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, March 3, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 10, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, November 7, 2023TEAS SECTION 71 & 15 RECEIVED
Wednesday, July 31, 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Wednesday, July 31, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Monday, July 29, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL